Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 31722-424

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 31722-424). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatinfigure1. (Atorvastatinfigure1)

Chemical structure of atorvastatin calcium, illustrating its molecular arrangement including phenyl rings, fluorine substitution, hydroxyl groups, and calcium salt form with associated water molecules.*

FDA Label Image

Atorvastatinfigure2. (Atorvastatinfigure2)

A line graph comparing the cumulative incidence percentages over time in years between Atorvastatin and placebo groups. The chart shows Atorvastatin with a lower cumulative incidence than placebo, with hazard ratio and p-value indicated in the legend.*

FDA Label Image

Atorvastatinfigure3. (Atorvastatinfigure3)

A line graph comparing cumulative hazard percentages over time from 0 to 5 years for Atorvastatin versus placebo. The x-axis shows years of follow-up, and the y-axis displays cumulative hazard percentages, illustrating a lower hazard for Atorvastatin with a hazard ratio (HR) of 0.63 (95% CI 0.48-0.83).*

FDA Label Image

Atorvastatinfigure4. (Atorvastatinfigure4)

A Kaplan-Meier survival curve graph comparing the time to the first major cardiovascular endpoint for Atorvastatin 10 mg and 80 mg dosages. The x-axis represents time in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes hazard ratio (HR 0.78) and p-value (0.0002) indicating statistical analysis results.*

FDA Label Image

Atorvastatinfigure5. (Atorvastatinfigure5)

Label for Atorvastatin Calcium Tablets, USP 10 mg by Camber Pharmaceuticals, Inc. The label indicates the product contains 90 film-coated tablets with a prescription-only status. Storage instructions specify 20° to 25°C, and a barcode is present along with manufacturer details from Camber Pharmaceuticals, Inc. and Anora Pharma Pvt Ltd.*

FDA Label Image

Atorvastatinfigure6. (Atorvastatinfigure6)

Atorvastatin Calcium Tablets USP 20 mg film-coated tablets label by Camber Pharmaceuticals, Inc. The label states the product contains 90 tablets and is for prescription use only. It includes storage instructions, manufacturer information, and a barcode. There is a pink unvarnished area measuring 40 x 35 mm on the right side.*

FDA Label Image

Atorvastatinfigure7. (Atorvastatinfigure7)

Label for Atorvastatin Calcium Tablets, USP 40 mg film-coated tablets, manufactured for Camber Pharmaceuticals, Inc. The label indicates a 90-tablet count and includes storage instructions, a barcode, and contact information. Tablets are produced by Annora Pharma Pvt. Ltd. in Telangana, India.*

FDA Label Image

Atorvastatinfigure8. (Atorvastatinfigure8)

Label for Atorvastatin Calcium Tablets, USP 80 mg by Camber Pharmaceuticals, Inc. The label states the product contains 80 mg atorvastatin per film-coated tablet, with 90 tablets per container. It includes storage instructions, a U.S. contact number, and manufacturer information showing production by Annora Pharma Pvt. Ltd. in India. A barcode and an unvarnish area of 43 x 50 mm are displayed.*

FDA Label Image

Atorvastatinfigure9 (Atorvastatinfigure9)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.